Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31915 total
DTCR heads into the back half of September with a notable split: the fund has gained 6.1% over the past week, yet the cost to borrow shares has climbed to a 30-day high — a quiet signal worth watching in an otherwise…
Unity Software heads into the final weeks of Q3 with an unusual tension: short sellers are slowly adding pressure while options traders are moving in the opposite direction, turning notably more bullish than they have…
Viatris enters the final stretch of September with an unusual combination: fresh analyst enthusiasm from multiple firms, a stock that has quietly added 5% over the past month, and short sellers who appear to be…
STLAM enters the final week of September with a troubling combination: executives selling shares on the way down, a stock that has lost 9% in a month, and a next earnings date that now looms as a genuine test of…
ORIC Pharmaceuticals heads into the final week of September with a rare alignment: fresh analyst conviction arriving just as short sellers pare back and the stock posts its best weekly performance in months. BTIG…
Weatherford International heads into its October 21 earnings report with a familiar tension: the Street remains firmly bullish but has been quietly trimming price targets for months, even as the stock slides and shorts…
Immunovant heads into the final weeks of September with an unusual tension: options traders are the most bullish they have been all year, yet short sellers have quietly been adding to positions over the past month. The…
Sibanye Stillwater enters the final week of September with a striking divergence between its lending market and its peer group — the borrow cost surged more than fourfold in a month while JSE stablemates trade in…
BUG, the Global X Cybersecurity ETF, is continuing its strong September run — but options traders are now the most defensively positioned they've been all year, even as the price adds another 2% on the week. The…
SITM heads into the week with an unusual split — the stock just rallied 15% in five days while short sellers rebuilt positions at the fastest weekly pace in months. The short-side move is worth naming clearly. Short…
BridgeBio Pharma enters the final week of September with a curious split: the stock has given back 15% over the past month yet recovered nearly 4% on Tuesday, while two of its largest activist investors have been…
CrowdStrike enters the final week of September with the narrative flipping decisively from the prior note: shorts who spent five consecutive sessions building positions have now begun to unwind, analysts are crowding…
Fastly enters the back half of September with a familiar tension: the stock is up 7% on the week yet shed nearly 5% on Tuesday alone, and three analysts raised price targets today — even as the short book stays…
FOXA heads into its October 14 earnings print with short sellers sitting near a year-long high and analysts sharply divided on the stock's direction. Short interest is the defining feature of the current setup. Bears…
Ardent Health, Inc. enters the final week of September with a striking divergence: options traders are the most bullishly positioned they've been all year, even as the ORTEX short score has jumped to its highest…
MRNA has ripped 27% in a single week to $182.56, and the shorts who built the largest position of the past year are now covering at speed. The scale of the short retreat is the week's defining feature. Short interest…
Ondas Inc. closes the week up 6.6% to $7.72, yet the underlying structure of this trade remains unchanged — a fully exhausted borrow market, an immovable short position, and options traders still more defensive than at…
Northwest Natural Holding Company heads into the final week of September with options traders at their most defensive in a year, even as short sellers begin to trim positions. The clearest tension this week sits in…
ESTC heads into the last week of September with a notable tension: insider selling at the executive level has been heavy, yet the analyst community is raising targets and the stock is holding up far better than most of…
NIO enters the final week of September with the lending market for its shares almost entirely locked up — a structural pressure point that has persisted for weeks and shows no sign of easing. The clearest story on NIO…
